PerkinElmer (RVTY): Net earnings per share (EPS TTM)

Symbol and logo of brand Revvity, Inc. (RVTY)

The stability of Revvity, Inc. (RVTY) is supported by a hybrid approach to component procurement and internal calibration control. The company's trailing 12-month net profit per share demonstrates a fundamental trend, where the 2.27 level records fresh values. The operational base relies on demand for diagnostic automation, despite geopolitical barriers to equipment exports and the severance of several international scientific ties.

RVTY Revvity, Inc. Net earnings per share for the last four quarters (02/21/2024 - 11/12/2026)

Analytical breakdowns and data insights for company Revvity Inc (RVTY)

- current quotes and average value forecast:
Price Chart Revvity, Inc.|RVTY - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Revvity, Inc.|RVTY - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Revvity|RVTY - Book Valuation of Business|Market Value to Book Value Ratio revvity.com|RVTY - Aggregate Asset Value
- issuer credit burden and liquidity indicators:
Total Debt to Capital Revvity, Inc.|RVTY - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio PerkinElmer|RVTY - Company Debts|Debt to Book Value Revvity, Inc.|RVTY - Company Long-Term Debt|Company Short-Term Debts Revvity|Quick Liquidity Indicator revvity.com
- earnings and multiples data:
RVTY - Profit After Payment of Taxes|Future Profit Revvity, Inc.|RVTY - Market Cap to Earnings|Projected Price to Earnings Revvity|RVTY - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Revvity, Inc.|RVTY - Operating income before deduction of amortization|Earnings per share for the last twelve months Revvity|RVTY - Earnings per share for the last 12 months|Quarterly EPS earnings growth revvity.com|RVTY - Net earnings per share growth this year|Expected earnings per share growth for next year Revvity, Inc.
Fundamental company valuation:Revvity, Inc. - RVTY
Manufactured products of Revvity Corp

The maturity of Revvity, Inc. (RVTY) infrastructure solutions in biomedicine converts into a stable cash flow, which the EPS TTM metric quantifies by dividing total annual profit by the number of shares. The trend of this indicator allows for an assessment of the real yield per share by excluding quarterly distortions, making this 12-month trailing net income per share chart a key indicator of business resilience.

Competitor analysis for Revvity, Inc.

A - Earnings per share for the last twelve months|Net earnings per share for the last four quarters questdiagnostics.com DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Sotera Health Company (SHC)|QDEL (quidel.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) OPK (OPKO Health)|CareDx Corp (CDNA) - Net earnings per one share for the last twelve months|MRVI: Net earnings per share for the last 12 months|FLGT: Earnings per share for the last twelve months|LAB (Standard BioTools Inc.) - Net earnings per share for the last 12 months|CTKB (cytekbio.com) - Earnings per share for the last twelve months|OSUR (OraSure) - Net earnings per share (EPS TTM)|Exagen Diagnostics (XGN) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months MDXH (MDxHealth Inc.)|Earnings per share for the last four quarters LUCD|Prenetics - Net earnings per share for the last 12 months|Insight Molecular Diagnostics, Inc. (IMDX) - Net earnings per one share for the last twelve months|TRIB: Net earnings per share for the last 12 months|Earnings per share for the trailing year PRPH (ProPhase Labs Inc)|AIMD: Net earnings per share (EPS TTM)|CODX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Heart Test Laboratories|Earnings per share for the last 12 months BMRA (biomerica.com)|Net earnings per share (EPS TTM) CDIO|Net earnings per share for the last 12 months Onconetix Inc ONCO|Virax Biolabs Group Ltd - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Bluejay Diagnostics Corp (BJDX)|AWH - Earnings per share for the last twelve months|Earnings per share for the trailing year AXDX (acceleratediagnostics.com)|CNTG (Centogene N.V.) - Net earnings per share for the last 12 months|ENZ (Enzo Biochem) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months FRES|GENE (GTG Labs) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months ME (23andMe Holding Co.)|PMD - Net earnings per one share for the last twelve months